PDB Short entry for 2M63 HEADER IMMUNE SYSTEM 20-MAR-13 2M63 TITLE THE PROTEASE-RESISTANT N-TERMINAL DOMAIN OF TIR-DOMAIN CONTAINING TITLE 2 ADAPTOR MOLECULE-1, TICAM-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TIR DOMAIN-CONTAINING ADAPTER MOLECULE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN, UNP RESIDUES 1-156; COMPND 5 SYNONYM: TICAM-1, PROLINE-RICH, VINCULIN AND TIR DOMAIN-CONTAINING COMPND 6 PROTEIN B, PUTATIVE NF-KAPPA-B-ACTIVATING PROTEIN 502H, TOLL- COMPND 7 INTERLEUKIN-1 RECEPTOR DOMAIN-CONTAINING ADAPTER PROTEIN INDUCING COMPND 8 INTERFERON BETA, MYD88-3, TIR DOMAIN-CONTAINING ADAPTER PROTEIN COMPND 9 INDUCING IFN-BETA; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TICAM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PGEX-6P KEYWDS TICAM-1, TRIF, INTERFERON, INNATE IMMUNITY, IMMUNE SYSTEM EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR H.KUMETA,Y.ENOKIZONO,H.SAKAKIBARA,K.OGURA,M.MATSUMOTO,T.SEYA, AUTHOR 2 F.INAGAKI REVDAT 3 14-JUN-23 2M63 1 REMARK REVDAT 2 24-AUG-22 2M63 1 JRNL SEQADV REVDAT 1 05-MAR-14 2M63 0 JRNL AUTH H.KUMETA,H.SAKAKIBARA,Y.ENOKIZONO,K.OGURA,M.HORIUCHI, JRNL AUTH 2 M.MATSUMOTO,T.SEYA,F.INAGAKI JRNL TITL THE N-TERMINAL DOMAIN OF TIR DOMAIN-CONTAINING ADAPTOR JRNL TITL 2 MOLECULE-1, TICAM-1. JRNL REF J.BIOMOL.NMR V. 58 227 2014 JRNL REFN ISSN 0925-2738 JRNL PMID 24500696 JRNL DOI 10.1007/S10858-014-9819-1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 6.1C, CYANA REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2M63 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-MAR-13. REMARK 100 THE DEPOSITION ID IS D_1000103255. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.75 MM [U-99% 13C; U-99% 15N] REMARK 210 TICAM-1_NTD-1, 3 MM DTT-2, 50 MM REMARK 210 SODIUM PHOSPHATE-3, 1 MM SODIUM REMARK 210 AZIDE-4, 0.02 MG/ML DSS-5, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 3D HNCO; 3D HN(CO)CA; REMARK 210 3D HNCA; 3D CBCA(CO)NH; 3D REMARK 210 HNCACB; 3D HBHA(CO)NH; 3D HN(CA) REMARK 210 HA; 3D C(CO)NH; 3D HCCH-TOCSY; REMARK 210 3D 1H-15N NOESY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : UNITY INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 PRO A -1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 3 123.66 -171.79 REMARK 500 1 PRO A 6 -167.38 -74.95 REMARK 500 1 ALA A 18 -64.65 -90.76 REMARK 500 1 TYR A 25 -75.41 -55.64 REMARK 500 1 LYS A 31 -33.29 -39.85 REMARK 500 1 THR A 55 -30.21 -38.87 REMARK 500 1 TRP A 77 -61.31 -109.51 REMARK 500 1 VAL A 80 165.19 -42.41 REMARK 500 1 ASP A 81 45.70 -80.83 REMARK 500 1 SER A 82 37.55 33.59 REMARK 500 1 VAL A 116 -38.08 -39.84 REMARK 500 1 ASP A 130 178.39 -53.93 REMARK 500 1 LEU A 133 -72.74 -51.77 REMARK 500 1 ARG A 143 -78.43 -83.61 REMARK 500 1 ASP A 147 60.14 -117.51 REMARK 500 2 ALA A 2 -71.70 -81.88 REMARK 500 2 PRO A 6 -169.53 -75.00 REMARK 500 2 ALA A 18 -76.28 -95.31 REMARK 500 2 THR A 55 -32.86 -38.45 REMARK 500 2 VAL A 80 -167.39 -55.35 REMARK 500 2 SER A 82 48.69 37.52 REMARK 500 2 GLU A 87 154.79 -38.96 REMARK 500 2 VAL A 92 -74.89 -44.78 REMARK 500 2 ARG A 123 -71.45 -89.80 REMARK 500 2 THR A 124 -39.11 -35.74 REMARK 500 2 ASP A 129 46.26 38.42 REMARK 500 2 ASP A 130 175.92 -58.29 REMARK 500 2 ARG A 143 -79.03 -85.81 REMARK 500 2 ASP A 147 61.60 -111.44 REMARK 500 3 PRO A 6 -162.42 -74.93 REMARK 500 3 SER A 7 147.65 177.54 REMARK 500 3 ALA A 18 -73.13 -98.17 REMARK 500 3 TYR A 25 -71.50 -47.99 REMARK 500 3 THR A 55 -31.29 -38.35 REMARK 500 3 VAL A 80 -168.05 -57.38 REMARK 500 3 SER A 82 49.54 38.46 REMARK 500 3 ARG A 123 -72.51 -89.19 REMARK 500 3 ASP A 130 174.05 -59.53 REMARK 500 3 ARG A 143 -78.92 -85.39 REMARK 500 3 ASP A 147 61.84 -112.26 REMARK 500 3 SER A 154 98.51 173.80 REMARK 500 4 CYS A 3 40.73 -108.49 REMARK 500 4 PRO A 6 -169.90 -74.93 REMARK 500 4 ALA A 18 -75.24 -89.84 REMARK 500 4 TYR A 25 -71.51 -45.73 REMARK 500 4 LYS A 31 -36.15 -38.40 REMARK 500 4 THR A 55 -34.37 -38.23 REMARK 500 4 ALA A 66 34.27 -97.82 REMARK 500 4 VAL A 80 -138.67 -61.16 REMARK 500 4 SER A 82 54.78 36.01 REMARK 500 REMARK 500 THIS ENTRY HAS 281 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19106 RELATED DB: BMRB DBREF 2M63 A 1 156 UNP Q8IUC6 TCAM1_HUMAN 1 156 SEQADV 2M63 GLY A -2 UNP Q8IUC6 EXPRESSION TAG SEQADV 2M63 PRO A -1 UNP Q8IUC6 EXPRESSION TAG SEQADV 2M63 HIS A 0 UNP Q8IUC6 EXPRESSION TAG SEQRES 1 A 159 GLY PRO HIS MET ALA CYS THR GLY PRO SER LEU PRO SER SEQRES 2 A 159 ALA PHE ASP ILE LEU GLY ALA ALA GLY GLN ASP LYS LEU SEQRES 3 A 159 LEU TYR LEU LYS HIS LYS LEU LYS THR PRO ARG PRO GLY SEQRES 4 A 159 CYS GLN GLY GLN ASP LEU LEU HIS ALA MET VAL LEU LEU SEQRES 5 A 159 LYS LEU GLY GLN GLU THR GLU ALA ARG ILE SER LEU GLU SEQRES 6 A 159 ALA LEU LYS ALA ASP ALA VAL ALA ARG LEU VAL ALA ARG SEQRES 7 A 159 GLN TRP ALA GLY VAL ASP SER THR GLU ASP PRO GLU GLU SEQRES 8 A 159 PRO PRO ASP VAL SER TRP ALA VAL ALA ARG LEU TYR HIS SEQRES 9 A 159 LEU LEU ALA GLU GLU LYS LEU CYS PRO ALA SER LEU ARG SEQRES 10 A 159 ASP VAL ALA TYR GLN GLU ALA VAL ARG THR LEU SER SER SEQRES 11 A 159 ARG ASP ASP HIS ARG LEU GLY GLU LEU GLN ASP GLU ALA SEQRES 12 A 159 ARG ASN ARG CYS GLY TRP ASP ILE ALA GLY ASP PRO GLY SEQRES 13 A 159 SER ILE ARG HELIX 1 1 PRO A 9 ALA A 17 1 9 HELIX 2 2 GLY A 19 LYS A 31 1 13 HELIX 3 3 GLY A 39 GLY A 52 1 14 HELIX 4 4 GLN A 53 ALA A 63 1 11 HELIX 5 5 ASP A 67 TRP A 77 1 11 HELIX 6 6 SER A 93 ALA A 104 1 12 HELIX 7 7 PRO A 110 ARG A 128 1 19 HELIX 8 8 ARG A 132 CYS A 144 1 13 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000